TFA
TNDM icon

Transamerica Financial Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Transamerica Financial Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256 Sell
17
-372
-96% -$6.5K ﹤0.01% 1827
2026
Q1 		$7.46K Hold
389
– – ﹤0.01% 972
2025
Q4 		$8.55K Hold
389
– – ﹤0.01% 871
2025
Q3 		$4.72K Buy
+389
New +$5.27K ﹤0.01% 883

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Transamerica Financial Advisors's TNDM Position: Q2 2026 in Review

Transamerica Financial Advisors reduced its Tandem Diabetes Care (TNDM) stake by 96% in Q2 2026, selling an estimated $6.5K and leaving 17 shares worth $256. The position accounts for ﹤0.01% of the portfolio, ranked #1827.

Transamerica Financial Advisors first reported a position in TNDM in Q3 2025 and has held it in 4 quarters since. The position peaked at $8.55K in Q4 2025. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Transamerica Financial Advisors held 17 shares of Tandem Diabetes Care worth $256 as of Q2 2026.
  • Transamerica Financial Advisors sold 372 Tandem Diabetes Care shares in Q2 2026, an estimated $6.5K.
  • Tandem Diabetes Care made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #1827 holding.
  • Transamerica Financial Advisors first reported a position in Tandem Diabetes Care in Q3 2025 and has held it in 4 quarters since.
  • Transamerica Financial Advisors's Tandem Diabetes Care position peaked at $8.55K in Q4 2025.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.